查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1722789

单纯疱疹病毒治疗市场报告：规模、份额、趋势及预测（按类型、药物类型、给药途径、配销通路和地区），2025 年至 2033 年

Herpes Simplex Virus Treatment Market Report Size, Share, Trends and Forecast by Type, Drug Type, Route of Administration, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球单纯疱疹病毒治疗市场规模价值 27 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 40 亿美元，2025-2033 年期间的复合年增长率为 4.51%。北美目前占据市场主导地位。人们对各种 HSV 药物的认识不断提高、医疗保健支出不断增加以及透过线上和线下药局广泛提供 HSV 药物是推动市场发展的一些关键因素。

单纯疱疹病毒 (HSV) 是一种传染性病毒感染，透过唾液、精液和阴道分泌物传播，并引起水疱和溃疡。它在个体之间产生单纯疱疹病毒-1（HSV-1）感染和单纯疱疹病毒-2（HSV-2）感染。它也会在出现疮之前引起发烧、身体疼痛、淋巴结肿大、头痛、刺痛、搔痒或口腔周围灼热感。此病通常发生在性伴侣患有 HSV 或免疫功能低下的人群中。可以透过服用一些抗病毒药物（例如阿昔洛韦、泛昔洛韦和伐昔洛韦）来治癒 HSV。也可以透过一些家庭疗法来治疗，例如热敷或冷敷、芦荟、小苏打或玉米淀粉和水的糊状物以及压碎的大蒜混合物。 HSV 治疗有助于降低病毒传播的机会并减少疫情爆发的频率或严重程度。

单纯疱疹病毒治疗市场趋势：

目前，全球性传播感染（STI）的盛行率不断上升是支撑市场成长的关键因素之一。此外，由于全球人们对性健康的担忧，对 HSV 治疗的需求不断增加，这也推动了市场的成长。除此之外，由于全球人们对 HSV 感染风险和併发症的认识不断提高，对 HSV 治疗的需求不断增长，这对市场产生了积极影响。此外，对副作用较小、疗效较高的新型 HSV 治疗方案的需求不断增长，也推动了市场的成长。除此之外，医疗保健支出的增加以及个人收入水准的提高，为行业投资者提供了丰厚的成长机会。此外，全球线上和线下药局广泛提供 HSV 药物，这也推动了市场的成长。除此之外，人们对 HSV 治疗方案的需求不断增加，以预防严重的併发症，如脑炎（脑部感染）或角膜炎（眼部感染），这也促进了市场的成长。此外，HSV 治疗方案的不断创新和各种药物的批准正在加强市场的成长。

本报告回答的关键问题

  • 单纯疱疹病毒治疗市场有多大？单纯疱疹病毒治疗市场的未来前景如何？
  • 推动单纯疱疹病毒治疗市场的关键因素有哪些？
  • 哪个地区占单纯疱疹病毒治疗市场的最大份额？
  • 全球单纯疱疹病毒治疗市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球单纯疱疹病毒治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 单纯疱疹病毒-1感染
  • 单纯疱疹病毒第二型感染
  • 其他的

第七章：市场区隔：依药物类型

  • 阿昔洛韦
  • 伐昔洛韦
  • 泛昔洛韦
  • 其他的

第八章：市场区隔：依行政途径

  • 口服
  • 注射剂
  • 外用

第九章：市场区隔：按配销通路

  • 医院药房
  • 药局
  • 零售店
  • 网路药局

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agenus Inc.
    • Apotex Inc.
    • Avet Pharmaceuticals Inc.
    • Carlsbad Tech
    • EPI Health LLC
    • F. Hoffmann-La Roche Ltd
    • Fresenius SE & Co. KGaA
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Novartis AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112025A5257

The global herpes simplex virus treatment market size was valued at USD 2.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.0 Billion by 2033, exhibiting a CAGR of 4.51% during 2025-2033. North America currently dominates the market. The growing awareness among individuals about various medications of HSV, increasing healthcare expenditure, and wide availability of HSV medications through online and offline pharmacy stores represent some of the key factors driving the market.

Herpes simplex virus (HSV) refers to a contagious viral infection that is spread through saliva, semen, and vaginal secretion and causes blisters and ulcers. It produces herpes simplex virus-1 (HSV-1) infection and herpes simplex virus-2 (HSV-2) infection among individuals. It also causes fever, body aches, swollen lymph nodes, headache, tingling, itching, or burning sensation around the mouth of an individual before the appearance of sores. It usually occurs among people having a sexual partner with HSV or who are immunocompromised. HSV can be cured by consuming some antiviral medications, such as acyclovir, famciclovir, and valacyclovir. It can also be treated through some home remedies, such as a warm or cold compress, aloe vera, a paste of baking soda or cornstarch and water, and a mixture of crushed garlic. HSV treatment can aid in lowering the chance of transmitting the virus and reducing the frequency or severity of outbreaks.

Herpes Simplex Virus Treatment Market Trends:

At present, the rising prevalence of sexually transmitted infections (STIs) among the masses around the world represents one of the key factors supporting the growth of the market. In addition, the increasing demand for HSV treatments due to concerns about sexual health among individuals worldwide is bolstering the growth of the market. Besides this, the growing demand for HSV treatments due to the increasing awareness among individuals about the risks and complications of HSV infection across the globe is positively influencing the market. Moreover, the rising demand for new HSV treatment options with reduced side effects and enhanced effectiveness is propelling the growth of the market. Apart from this, the increasing healthcare expenditure, along with the inflating income level of individuals, is offering lucrative growth opportunities to industry investors. Additionally, the wide availability of HSV medications through online and offline pharmacy stores across the globe is impelling the growth of the market. Besides this, the increasing demand for HSV treatment options to prevent severe complications, such as encephalitis (brain infection) or keratitis (eye infection) among individuals, is contributing to the growth of the market. Furthermore, the rising innovations in HSV treatment options and various drug approvals are strengthening the growth of the market.

Key Market Segmentation:

Type Insights:

  • Herpes Simples Virus-1 Infection
  • Herpes Simplex Virus-2 Infection
  • Others

Drug Type Insights:

  • Acyclovir
  • Valacyclovir
  • Famciclovir
  • Others

Route of Administration Insights:

  • Oral
  • Injectable
  • Topical

Distribution Channel Insights:

  • Hospital Pharmacy
  • Drug Stores
  • Retail Stores
  • Online Pharmacy

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for herpes simplex virus treatment. Some of the factors driving the North America herpes simplex virus treatment market included the growing prevalence of HSV infection among individuals, increasing number of clinical trials for its treatment, rising awareness about various medications of HSV, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global herpes simplex virus treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the herpes simplex virus treatment market?
  • 2.What is the future outlook of the herpes simplex virus treatment market?
  • 3.What are the key factors driving the herpes simplex virus treatment market?
  • 4.Which region accounts for the largest herpes simplex virus treatment market share?
  • 5.Which are the leading companies in the global herpes simplex virus treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Herpes Simplex Virus Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Herpes Simples Virus-1 Infection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Herpes Simplex Virus-2 Infection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Acyclovir
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Valacyclovir
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Famciclovir
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Online Pharmacy
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agenus Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Apotex Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Avet Pharmaceuticals Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Carlsbad Tech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 EPI Health LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Fresenius SE & Co. KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Glenmark Pharmaceuticals Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Merck & Co. Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Novartis AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Teva Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Viatris Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
  • Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
  • Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
  • Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players